Stock Earnings

Question 1

Genelux Corp 的關鍵財務報表是什麼？

Accepted Answer

根據最新的財務報表（Form-10K），Genelux Corp 的總資產為 $34，淨loss為 $-29

Question 2

GNLX 的關鍵財務比率是什麼？

Accepted Answer

Genelux Corp 的流動比率為 4.25，淨利潤率為 0，每股銷售為 $0。

Question 3

Genelux Corp 的收入按細分市場或地理位置如何劃分？

Accepted Answer

Genelux Corp largest revenue segment is Oncolytic Immunotherapies, at a revenue of 8,000 in the most earnings release.For geography, United States is the primary market for Genelux Corp, at a revenue of 8,000.

Question 4

Genelux Corp 是否盈利？

Accepted Answer

no，根據最新的財務報表，Genelux Corp 的淨loss為 $-29

Question 5

Genelux Corp 有負債嗎？

Accepted Answer

yes，Genelux Corp 的負債為 8

Question 6

Genelux Corp 的流通股有多少？

Accepted Answer

Genelux Corp 的總流通股為 34.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	11	0	0
Revenue Growth (YoY)	--	--	-100%	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	12	12	11	5	8	6
Research & Development	15	18	12	9	6	6
Operating Expenses	31	31	24	14	14	12
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-30	-29	-28	-4	-16	-13
Income Tax Expense	--	0	0	1	0	0
Net Income	-30	-29	-28	-5	-16	-13
Net Income Growth	15%	4%	459.99%	-69%	23%	18%
Shares Outstanding (Diluted)	37.94	31.45	24.42	24.55	23.65	23.65
Shares Change (YoY)	26%	28.99%	0%	4%	0%	0%
EPS (Diluted)	-0.8	-0.94	-1.15	-0.21	-0.69	-0.58
EPS Growth	-9%	-18%	451.99%	-70%	19%	18%
Free Cash Flow	-22	-21	-21	-3	-6	-7
Free Cash Flow Per Share	-0.57	-0.66	-0.85	-0.12	-0.25	-0.29
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-27.27%	0%	0%
Profit Margin	0%	0%	0%	-45.45%	0%	0%
Free Cash Flow Margin	0%	0%	0%	-27.27%	0%	0%
EBITDA	-31	-31	-24	-3	-14	-12
EBITDA Margin	0%	0%	0%	-27.27%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-31	-31	-24	-3	-14	-12
EBIT Margin	0%	0%	0%	-27.27%	0%	0%
Effective Tax Rate	--	0%	0%	-25%	0%	0%

Genelux Corp (GNLX) Price

GNLX Stock Price Chart

GNLX Income

Follow-Up Questions